Target Therapeutics expects to complete GDC recall in two weeks.
This article was originally published in The Gray Sheet
Executive Summary
TARGET THERAPEUTICS GUGLIELMI DETACHABLE COIL RECALL expected to be completed within two weeks, the company says. The recall of two lots of the GDC coils was initiated the week of July 29 following receipt of a complaint the previous week "related to difficulty in the fluoroscopic visualization of the marker on the delivery wires" of certain lots of the GDC device, the company says in a July 30 release. The action affects less than 5% of GDC inventory in domestic and overseas hospitals, Target estimates.